Status:
COMPLETED
Using Clonidine to Improve Leg Weakness in People With Heart Failure
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heart Failure
Eligibility:
All Genders
21-65 years
Phase:
PHASE4
Brief Summary
People with heart failure often have weakness in their leg muscles. This study will determine whether the leg weakness is due to very high adrenaline levels and whether the medication clonidine can im...
Detailed Description
Heart failure is a common condition, affecting approximately 5 million people in the United States. People with heart failure are encouraged to exercise and lose weight. However, many people with hear...
Eligibility Criteria
Inclusion
- Heart failure
Exclusion
- Currently on Coumadin therapy
- Experienced a heart attack in the 3 months before study entry
- Medically unable to receive clonidine
- Advanced kidney or liver disease
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00858845
Start Date
May 1 2008
End Date
December 1 2012
Last Update
May 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles Medical Center
Los Angeles, California, United States, 90095